Vigabatrin
| CAS No. | 60643-86-9 | Cat. No. | BCP16220 |
| Name | Vigabatrin | ||
| Synonyms | gamma-vinyl-GABA;CPP109; CPP-109; CPP 109; RMI 71754; RMI71754; RMI-71754; MDL 71754; MDL-71754; MDL71754; | ||
| Formula | C6H11NO2 | M. Wt | 129.16 |
| Description | Vigabatrin is an antiepileptic drug that inhibits the breakdown of γ-aminobutyric acid (GABA) by acting as a suicide inhibitor of GABA transaminase (GABA-T). It is a structural analog of GABA, but does not bind to GABA receptors. Vigabatrin is an irreversible suicide inhibitor of gamma-aminobutyric acid transaminase (GABA-T), the enzyme responsible for the catabolism of GABA, which increases the level of GABA in the brain. Vigabatrin is a racemic compound, and its [S]-enantiomer is pharmacologically active. | ||
| Pathways | Ion Channel/Membrane Transporter | ||
| Targets | GABA Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.